Soluble endoglin as a biomarker of successful rheopheresis treatment in patients with age-related ma...
Soluble endoglin as a biomarker of successful rheopheresis treatment in patients with age-related macular degeneration
About this item
Full title
Author / Creator
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
Age-related macular degeneration (AMD) is a progressive chronic disease causing visual impairment or central vision loss in the elderly. We hypothesized that successful rheopheresis would be associated with positive changes in soluble endoglin (sENG), PSCK9, alpha-2-macroglobulin (A2M), and hs-CRP levels. 31 elderly patients with the dry form of AM...
Alternative Titles
Full title
Soluble endoglin as a biomarker of successful rheopheresis treatment in patients with age-related macular degeneration
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_b6346e3cb6c94c9eb52f8a19d32e83e0
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_b6346e3cb6c94c9eb52f8a19d32e83e0
Other Identifiers
ISSN
2045-2322
E-ISSN
2045-2322
DOI
10.1038/s41598-024-80375-5
